Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct:79:79-85.
doi: 10.1016/j.parkreldis.2020.08.001. Epub 2020 Aug 23.

Linear predictive coding distinguishes spectral EEG features of Parkinson's disease

Affiliations

Linear predictive coding distinguishes spectral EEG features of Parkinson's disease

Md Fahim Anjum et al. Parkinsonism Relat Disord. 2020 Oct.

Abstract

Objective: We have developed and validated a novel EEG-based signal processing approach to distinguish PD and control patients: Linear-predictive-coding EEG Algorithm for PD (LEAPD). This method efficiently encodes EEG time series into features that can detect PD in a computationally fast manner amenable to real time applications.

Methods: We included a total of 41 PD patients and 41 demographically-matched controls from New Mexico and Iowa. Data for all participants from New Mexico (27 PD patients and 27 controls) were used to evaluate in-sample LEAPD performance, with extensive cross-validation. Participants from Iowa (14 PD patients and 14 controls) were used for out-of-sample tests. Our method utilized data from six EEG leads which were as little as 2 min long.

Results: For the in-sample dataset, LEAPD differentiated PD patients from controls with 85.3 ± 0.1% diagnostic accuracy, 93.3 ± 0.5% area under the receiver operating characteristics curve (AUC), 87.9 ± 0.9% sensitivity, and 82.7 ± 1.1% specificity, with multiple cross-validations. After head-to-head comparison with state-of-the-art methods using our dataset, LEAPD showed a 13% increase in accuracy and a 15.5% increase in AUC. When the trained classifier was applied to a distinct out-of-sample dataset, LEAPD showed reliable performance with 85.7% diagnostic accuracy, 85.2% AUC, 85.7% sensitivity, and 85.7% specificity. No statistically significant effect of levodopa-ON and levodopa-OFF sessions were found.

Conclusion: We describe LEAPD, an efficient algorithm that is suitable for real time application and captures spectral EEG features using few parameters and reliably differentiates PD patients from demographically-matched controls.

Keywords: Classifier; Diagnosis; EEG; Parkinson's disease.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest:

None

Figures

Figure 1.
Figure 1.
Comparison of PSD shapes and band power between PD and control: (A) Comparison of EEG recordings (eyes open + closed) highlighting the difference in PSD shapes at 2.5–14 Hz between PD (n = 27) and control (n = 27) subjects (UNM data). (B) Comparison of theta (4–8 Hz), alpha (8–12 Hz) and beta (12–32 Hz) band power for the same data set. All plots: mean ± standard deviation.
Figure 2.
Figure 2.
Classification method:(A) Detailed flow chart of a single-channel PD vs. control classifier. (B) Simplified diagram for the multi-channel classification with six single-classifier collaboration. (C) Performance comparison of 62 channels (UNM data). (D) Comparison of the 10 top-performing channels. (E) Channel positions of the 6 top-performing channels; red indicates selected or multi-channel classification.
Figure 3.
Figure 3.
Classifier performance: (A) Performance evaluation of the proposed method with receiver-operative characteristic (ROC) curve (top left), accuracy (top right), and boxplots (bottom). (B) Performance comparison of the proposed method (LEAPD) with traditional approaches (Yuvaraj 2018 [8], Vanneste 2018 [10] and Chaturvedi 2017 [7]) using ROC curve (top left), accuracy (top right), and boxplots (bottom).

References

    1. Fahn S, The history of dopamine and levodopa in the treatment of Parkinson’s disease, 23(S3) (2008) S497–S508. - PubMed
    1. Chaudhuri KR, Schapira AHV, Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment, The Lancet Neurology 8(5) (2009) 464–474. - PubMed
    1. Little S, Pogosyan A, Neal S, Zavala B, Zrinzo L, Hariz M, Foltynie T, Limousin P, Ashkan K, FitzGerald J, Green AL, Aziz TZ, Brown P, Adaptive deep brain stimulation in advanced Parkinson disease, Ann Neurol 74(3) (2013) 449–457. - PMC - PubMed
    1. Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G, Accuracy of clinical diagnosis of Parkinson disease, A systematic review and meta-analysis 86(6) (2016) 566–576. - PubMed
    1. Singh A, Cole RC, Espinoza AI, Brown D, Cavanagh JF, Narayanan NS, Frontal theta and beta oscillations during lower-limb movement in Parkinson’s disease, Clinical Neurophysiology 131(3) (2020) 694–702. - PMC - PubMed

Publication types